BACKGROUND AND OBJECTIVES: Left ventricular hypertrophy (LVH) is an independent risk factor for premature cardiovascular death in hemodialysis (HD) patients and one of the three forms of uremic cardiomyopathy. Cardiovascular magnetic resonance (CMR) is a volume-independent technique to assess cardiac structure. We used CMR to assess the determinants of left ventricular mass (LVM) and LVH in HD patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 246 HD patients (63.8% male; mean age 51.5 +/- 12.1 yr) underwent CMR on a postdialysis day. LVM was measured from a stack of cine loops and indexed for body surface area (LVM index [LVMI]). Demographic, past biochemical, hematologic, and dialysis data were collected by patient record review. Results up to 180 d before CMR were collected. LVH was defined as LVMI >84.1 g/m(2) (male) or >76.4 g/m(2) (female). RESULTS: A total of 157 (63.8%) patients had LVH. LVH was more common in patients with higher predialysis systolic BP, predialysis pulse pressure, and calcium-phosphate product (Ca X PO4). Furthermore, LVH was significantly associated with higher end-diastolic and systolic volumes and lower ejection fraction. There were positive correlations with LVMI and end-diastolic and systolic volumes. There were weak positive correlations among LVMI, mean volume of ultrafiltration, and Ca X PO4. Using multivariate linear and logistic regression (entering one BP and cardiac variable), the independent predictors of LVMI and LVH were end-diastolic volume, predialysis systolic BP, and Ca X PO4. CONCLUSIONS: The principal determinants of LVM and LVH in HD patients are end-diastolic LV volume, predialysis BP, and Ca X PO4.
BACKGROUND AND OBJECTIVES:Left ventricular hypertrophy (LVH) is an independent risk factor for premature cardiovascular death in hemodialysis (HD) patients and one of the three forms of uremic cardiomyopathy. Cardiovascular magnetic resonance (CMR) is a volume-independent technique to assess cardiac structure. We used CMR to assess the determinants of left ventricular mass (LVM) and LVH in HDpatients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 246 HDpatients (63.8% male; mean age 51.5 +/- 12.1 yr) underwent CMR on a postdialysis day. LVM was measured from a stack of cine loops and indexed for body surface area (LVM index [LVMI]). Demographic, past biochemical, hematologic, and dialysis data were collected by patient record review. Results up to 180 d before CMR were collected. LVH was defined as LVMI >84.1 g/m(2) (male) or >76.4 g/m(2) (female). RESULTS: A total of 157 (63.8%) patients had LVH. LVH was more common in patients with higher predialysis systolic BP, predialysis pulse pressure, and calcium-phosphate product (Ca X PO4). Furthermore, LVH was significantly associated with higher end-diastolic and systolic volumes and lower ejection fraction. There were positive correlations with LVMI and end-diastolic and systolic volumes. There were weak positive correlations among LVMI, mean volume of ultrafiltration, and Ca X PO4. Using multivariate linear and logistic regression (entering one BP and cardiac variable), the independent predictors of LVMI and LVH were end-diastolic volume, predialysis systolic BP, and Ca X PO4. CONCLUSIONS: The principal determinants of LVM and LVH in HDpatients are end-diastolic LV volume, predialysis BP, and Ca X PO4.
Authors: G A Stewart; J Foster; M Cowan; E Rooney; T McDonagh; H J Dargie; R S Rodger; A G Jardine Journal: Kidney Int Date: 1999-12 Impact factor: 10.612
Authors: Khaled Alfakih; Sven Plein; Holger Thiele; Tim Jones; John P Ridgway; Mohan U Sivananthan Journal: J Magn Reson Imaging Date: 2003-03 Impact factor: 4.813
Authors: Sergio F F Santos; Roger B Mendes; Carlos A Santos; David Dorigo; Aldo J Peixoto Journal: Am J Nephrol Date: 2003 Mar-Apr Impact factor: 3.754
Authors: Gérard M London; Bruno Pannier; Alain P Guerin; Jacques Blacher; Sylvain J Marchais; Bernadette Darne; Fabien Metivier; Hassan Adda; Michel E Safar Journal: J Am Soc Nephrol Date: 2001-12 Impact factor: 10.121
Authors: Kai Ming Chow; Cheuk Chun Szeto; Leo Chi-Chiu Kum; Bonnie Ching Ha Kwan; Terence Ming-Kit Fung; Teresa Yuk-Hwa Wong; Chi Bon Leung; Philip Kam-Tao Li Journal: J Nephrol Date: 2003 Nov-Dec Impact factor: 3.902
Authors: Christopher T Chan; George A Kaysen; Gerald J Beck; Minwei Li; Joan Lo; Michael V Rocco; Alan S Kliger Journal: Am J Nephrol Date: 2018-04-05 Impact factor: 3.754
Authors: Colin R Lenihan; Sai Liu; Medha Airy; Carl Walther; Maria E Montez-Rath; Wolfgang C Winkelmayer Journal: Cardiorenal Med Date: 2021-09-02 Impact factor: 4.360
Authors: Jonathan P Law; Luke Pickup; Davor Pavlovic; Jonathan N Townend; Charles J Ferro Journal: J Hum Hypertens Date: 2022-09-22 Impact factor: 2.877
Authors: Ron Wald; Marc B Goldstein; Rachel M Wald; Ziv Harel; Anish Kirpalani; Jeffrey Perl; Darren A Yuen; Myles S Wolf; Andrew T Yan Journal: Int J Cardiovasc Imaging Date: 2013-11-30 Impact factor: 2.357
Authors: Mark R Marshall; Alain C Vandal; Janak R de Zoysa; Ruvin S Gabriel; Imad A Haloob; Christopher J Hood; John H Irvine; Philip J Matheson; David O R McGregor; Kannaiyan S Rabindranath; John B W Schollum; David J Semple; Zhengxiu Xie; Tian Min Ma; Rose Sisk; Joanna L Dunlop Journal: J Am Soc Nephrol Date: 2020-03-18 Impact factor: 10.121
Authors: Kathryn K Stevens; Emily P McQuarrie; William Sands; Dianne Z Hillyard; Rajan K Patel; Patrick B Mark; Alan G Jardine Journal: Int J Nephrol Date: 2011-08-09